The contraceptives market is anticipated to undergo steady growth sue to increasing public awareness about reproductive health, prime driving factors of the global contraceptives market are technical advancement, preference for avoiding unintentional pregnancy and availability of highly effective female contraceptives.
This report on global novel drug delivery systems (NDDS) studies the overall market scenario, the ongoing trends, future commercial prospects and the competition in the novel drug delivery systems market. For the purpose of this study, the global novel drug delivery systems market is studied for route of administration type, carrier type, and geographical distribution. This study estimates the future prospects of the NDDS, post introduction of certain novel drug delivery systems market.
The study covers the basic overview of the hyaluronic acid market such as introduction, classification, and supply chain among others. In addition, to understand the competitiveness of the market porter’s five force analysis is also included.
Various drug delivery technologies assist in adjusting dosage release with best possible safety and efficacy. Drug delivery technologies simplify the challenge of patient compliance, facilitate precision in dosage and reduce side effects. For the purpose of this study, the global drug delivery devices market is studied in terms of mode of administration and geography.
The Injection Molded Plastic Market is expected to grow at a compound annual growth rate of 4.6% for the forecasted period. The rise is primarily due to broad range of applications in ever-expanding industries. Plastic injection molding is the process of melting plastic pellets (thermosetting/thermoplastic polymers) and injecting them at high pressure into a mold cavity, which fills and hardens in order to form a finished product. This report covers all the quantitative aspects of the injection molded plastic market and also talks about its key drivers, the challenges it faces, the growth opportunities present in the market, and its future prospects.
The enhanced oil recovery (EOR) market involves techniques used to increase the amount of crude oil that can be extracted from an oil field. Typically applied to aging oil fields, EOR employs various methods to extend the field's productive life by improving the extraction efficiency beyond what traditional pumping achieves. The primary techniques used in EOR include chemical injection, thermal recovery, and gas injection, each aimed at lowering the oil's viscosity or altering the reservoir's properties to enhance oil flow to the production wells. The enhanced oil recovery market is projected to grow at a compound annual growth rate (CAGR) of 4.5%.
The drug delivery market includes devices, formulations and technologies used to administer pharmaceutical products and biologics to patients. Drug delivery systems are designed to improve treatment effectiveness, control the release of active ingredients, increase patient convenience and deliver medicines to specific areas of the body. The category covers oral, injectable, transdermal, pulmonary, nasal, ocular, topical, transmucosal and implantable delivery systems.
The global drug delivery devices market is expected to demonstrate steady growth through 2035. One current industry estimate projects the market to increase from approximately USD 303.28 billion in 2025 to USD 533.31 billion by 2035, representing a compound annual growth rate of 5.81% during 2026–2035. North America held the largest regional share in 2025, while Asia-Pacific is projected to record notable growth. Oral delivery held a leading position by administration route, while home healthcare is expected to become an important end-user segment.
Increasing prevalence of diabetes, cancer, cardiovascular disorders, respiratory conditions and autoimmune diseases is a major market driver. Patients with chronic conditions frequently require long-term treatment, creating demand for reliable and convenient drug delivery products. Growth in biologics, vaccines, peptides, cell therapies and gene therapies is also increasing the need for specialized delivery systems capable of protecting sensitive medicines and improving their absorption.
Self-administration is an important market trend. Prefilled syringes, autoinjectors, pen injectors, wearable injectors and connected inhalers allow patients to receive treatment outside hospitals and clinics. These products can improve treatment adherence and reduce pressure on healthcare facilities. Demand for home-based care is therefore creating opportunities for simple, safe and digitally connected delivery devices.
Targeted and controlled-release technologies are also gaining importance. Nanoparticles, liposomes, microneedles, implants and long-acting injectable formulations can deliver medicines over an extended period or direct them toward specific tissues. These methods may reduce dosing frequency and unwanted side effects. Smart delivery systems incorporating sensors, mobile applications and dose-tracking functions are supporting remote patient monitoring.
Market expansion may be restrained by high product-development costs, complex manufacturing requirements and lengthy regulatory approval processes. Device failures, dosing errors and product recalls can create safety and commercial risks. Advanced drug delivery systems must also demonstrate compatibility with pharmaceutical formulations, reliable performance and cost-effectiveness. Limited healthcare access and reimbursement restrictions may affect adoption in developing markets.
North America benefits from strong pharmaceutical research, advanced healthcare infrastructure and early adoption of self-injection devices. Europe remains important for biologics and medical-device development. Asia-Pacific provides growth opportunities through expanding healthcare expenditure, pharmaceutical manufacturing and increasing chronic disease prevalence.
Acute Market Reports provides drug delivery market research covering administration routes, products, technologies, applications, end users, competitive developments and regional opportunities. These reports help pharmaceutical companies, device manufacturers, healthcare providers and investors evaluate market demand and growth prospects through 2035.